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E2F1 amplified in malignant melanomas
With early detection, malignant melanoma is curable by sur-
gery; however, following metastasis, melanoma is virtually 
resistant to all treatments. With the diagnosis of 50,000 peo-
ple in the United States this year, development of new treat-
ments is crucial. Previous work demonstrated increased copies 
of the long arm of chromosome 20 with a unique transloca-
tion involving 20q11 in melanoma cells. E2F1, a transcription 
factor important for mediation of the cell cycle G1-to-S-phase 
transition, maps to this location. Nelson and colleagues found 
that the E2F1 gene is amplified in both melanoma cell lines 
and archival metastatic biopsy samples. Increased E2F1 pro-
tein levels confirmed this finding. RNAi knockdown decreased 
the cellular proliferation, suggesting that E2F1 amplification is 
critical for transformation. Increased levels of E2F1 may prevent  
inhibitory complexes from sequestering this transcription fac-
tor from its downstream cell proliferation target genes during 
G1. Clinically, these results may direct the design of antican-
cer agents to the downstream target genes of E2F1. (Cancer Biol 
Ther 5:e1–6, 2006)
Pumping iron for strong pigment
Ferritin regulates intracellular iron levels, and iron depletion 
induces cell cycle arrest and apoptosis. Metastatic human 
melanoma cell lines display overexpression of the ferritin 
light chain (L-ferritin). Picardo and colleagues recently dem-
onstrated that downmodulation of L-ferritin in these metastatic 
melanoma cells induces a less pigmented phenotype accom-
panied by a decrease in tyrosinase activity. Tyrosinase, a key 
enzyme for melanin production, remained in its immature form 
in the endoplasmic reticulum and failed to be transported to 
the Golgi apparatus. Thus, the oxidative stress generated by 
L-ferritin downmodulation significantly affects the pigmentation 
pathway in melanoma cells. These results are particularly inter-
esting with regard to clinical iron manipulation in melanomas 
as well as in a related pigmentation condition, vitiligo. (J Cell 
Physiol 206:843–8, 2006)
Redundant pumps keep calcium moving
The extracellular calcium concentration must be converted to 
an intracellular signal to ensure proper function and survival 
of keratinocytes. Detection of this signal by plasma membrane-
bound receptors translates into intracellular release of the 
calcium stores in both the endoplasmic reticulum (ER) and 
the Golgi apparatus. Two similar acantholytic skin diseases, 
Hailey-Hailey disease and Darier’s disease (DD), are caused 
by mutations in two different calcium ATPases, human secre-
tory pathway Ca2+ ATPase-1 (hSPCA1) and sarcoplasmic and 
endoplasmic reticulum Ca2+ ATPase-2 (SERCA2), respectively. 
These ATPases are responsible for maintaining the ER and Golgi 
calcium stores. Recent work by Mauro and colleagues demon-
strated that although calcium stores in the ER were decreased, 
DD keratinocytes were capable of preserving the Ca2+ signaling 
and response to extracellular Ca2+ levels. Signaling through the 
Golgi calcium ATPase apparently compensates for the defective 
ER calcium stores caused by deficient SERCA2-dependent sig-
naling. (J Cell Sci 119:671–9, 2006)
α-catenin loss mirrors squamous-cell 
carcinomas
Cell adhesion is maintained by a pathway that includes 
E-cadherin, β-catenin, and α-catenin. Mutations in these genes 
have been previously identified in some human cancers. In 
fact, reduced E-cadherin and α-catenin signal a poor progno-
sis for squamous-cell carcinoma (SCC) patients. Kobielak and 
Fuchs recently grafted skin of an α-catenin conditional knock-
out mouse onto nude (nu/nu) mice to examine the effects on 
epidermal function and gene expression. Like human SCCs, the 
grafts were hyperproliferative with decreased E-cadherin levels 
and were dysplastic. Importantly, activation of NF-κB and con-
comitant upregulation of NF-κB wound-responsive and inflam-
matory target genes were observed. The progressive events 
displayed by the α-catenin-ablated grafts mirror the natural 
transition from benign hyperplasia to invasive SCC in humans. 
Reduced α-catenin and NF-κB activation are features of a vari-
ety of cancers, and thus this mechanism may be common to 
other types of cancers. (Proc Natl Acad Sci USA 103:2322–7, 
2006)
Leaky pipes amplify autoimmune attack
Organ-specific autoimmune disease was thought to stem from 
B- and T-cell self-reactivity to an antigen expressed in a certain 
cell type in that organ. Emerging evidence suggests that other 
mechanisms of autoimmunity can also direct the symptoms 
to a specific organ. Benoist and colleagues recently demon-
strated that vascular leakage localized to the distal extremities 
promotes organ-specific autoimmune arthritis. Mice received 
serum from K/BxN T-cell receptor-transgenic mice, a model 
of inflammatory arthritis in which the autoreactive T cells are 
specific to the ubiquitously expressed glucose-6-phosphate 
isomerase. These mice displayed rapid extravasation of a vas-
cular probe specifically in the paws. Immunocomplexes were 
implicated as causative agents in the serum. Administration of 
this serum to mice deficient in other suspect factors and cell 
types indicated that mast cells, neutrophils, and IgG Fc recep-
tor signaling are required. Although vascular leakage may not 
be absolutely essential for genesis of arthritic lesions, it serves 
as an important amplifier in early disease stages. These findings 
may prompt the development of treatments to minimize vascu-
lar leakage in the extremities in arthritis patients. (Nat Immunol 
7:284–92, 2006)
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